In a new Yale-led study, investigators have revealed previously unknown factors that contribute to the hardening of arteries and plaque growth, which cause heart disease. Their insight is the basis for a promising therapeutic approach to halt and potentially reverse plaque buildup and the progression of disease, the researchers said.
Current treatments for plaque and hardened arteries, a condition known as atherosclerosis, can slow but not improve the disease. Experts believe that may be due to ongoing inflammation in blood vessels. To understand the factors contributing to this inflammation, the research team focused on a group of proteins, called transforming growth factor beta (TGFß), that regulates a wide range of cells and tissues throughout the body.
Using cultured human cells, the researchers discovered that TGF? proteins trigger inflammation in endothelial cells — the cells that form the inner lining of artery walls — but not in other cell types. With a technique called single cell RNA-seq analysis, which measures the expression of every gene in single cells, they then showed that TGF? induced inflammation in these cells in mouse models. This finding was notable, said the researchers, because TGF? proteins are known to decrease inflammation in other cells in the body.
The researchers also showed that when the TGF? receptor gene is deleted in endothelial cells, both the inflammation and plaque in blood vessels are significantly reduced.
To test this approach as a potential therapy, the team, led by professor of medicine Michael Simons, M.D., used an “interfering” RNA, or RNAi, drug developed at Yale, to disrupt TGFß receptors. Interfering RNA use a gene’s own DNA sequence to turn off or silence the gene. To deliver the drug only to endothelial cells in the blood vessel walls of mice, they employed microscopic particles, or nanoparticles, created by their co-authors at MIT. This strategy reduced inflammation and plaque as effectively as the genetic technique.
The findings identify TGFß signaling as a major cause of chronic vessel wall inflammation, and demonstrate that disruption of this pathway leads to cessation of inflammation and substantial regression of existing plaque, said the scientists.
Based on this discovery, investigators at Yale and MIT have launched a biotech company, VasoRX, Inc., to develop this targeted approach, using the RNAi drug delivered by nanoparticles as a potential therapy for atherosclerosis in people.
The Latest on: Atherosclerosis
via Google News
The Latest on: Atherosclerosis
- The implant that can perk up a man's love life: Tube that props open blood vessels could conquer impotenceon April 12, 2021 at 5:54 pm
A tube that props open tiny blood vessels may offer a new way to tackle impotence. The wire tube is implanted inside the tiny arteries measuring just 1mm wide that supply blood to the penis.
- Intake of food rich in saturated fat in relation to subclinical atherosclerosis and potential modulating effects from single genetic variantson April 12, 2021 at 2:07 pm
The relationship between intake of saturated fats and subclinical atherosclerosis, as well as the possible influence of genetic variants, is poorly understood and investigated. We aimed to investigate ...
- Researchers explain how high blood pressure accelerates atherosclerosison April 12, 2021 at 10:05 am
High blood pressure, the most important cause of disease worldwide, accelerates atherosclerosis but the mechanism is unknown. Using gene modified minipigs, researchers from the Centro Nacional de ...
- Another way 'good' cholesterol is good: combatting inflammationon April 12, 2021 at 2:14 am
Testing how well "good" cholesterol particles reduce inflammation may help predict who is at heightened risk to develop cardiovascular disease caused by narrowed arteries, according to research ...
- New research on good cholesterol possibly finds better marker for cardiovascular diseaseon April 11, 2021 at 9:00 pm
Good cholesterol, which is transported in HDLs (high-density lipoproteins), plays a key part in the prevention of atherosclerosis and thus the risk of cardiovascular disease. However, according to a ...
- CNIC researchers explain how high blood pressure, the most important cause of disease worldwide, accon April 11, 2021 at 9:00 pm
Researchers from the CNIC and Aarhus University (Denmark), demonstrate that high blood pressure alters the structure of arteries leading to more accumulation of LDL cholesterol and faster development ...
- For U.S. Immigrants, Cultural Changes and Heart Risks Go Hand in Handon April 9, 2021 at 12:32 pm
Immigrants to the U.S. who adopted conventional North American lifestyles tended to have worse cardiovascular health, according to data from the Multi-Ethnic Study of Atherosclerosis (MESA). Greater ...
- Smooth muscle-specific HuR knockout induces defective autophagy and atherosclerosison April 9, 2021 at 9:43 am
Atherosclerosis is a chronic and systemic vascular inflammatory process, the pathological basis of coronary artery disease, myocardial infarction, and stroke 1. Despite many treatment options ...
- SVEP1 is a human coronary artery disease locus that promotes atherosclerosison April 4, 2021 at 5:01 pm
studied the role of this extracellular matrix protein in atherosclerosis. SVEP1 was expressed by vascular smooth muscle cells in human tissue samples from patients with atherosclerosis and was ...
- Gene Found to Play a Role in Atherosclerosison April 1, 2021 at 3:58 pm
Atherosclerosis, the accumulation of plaque inside artery walls, can lead to heart attacks and strokes. There are many factors that can contribute to the weakening of the arteries and increasing ...
via Bing News